arrow_back Back to App

New Health Research Agency: Breakthrough Medical Technologies

This act establishes a new government agency, ARPA-H, aimed at accelerating the development of innovative medical technologies. This is intended to lead to better detection, diagnosis, and treatment of serious diseases, as well as reduce healthcare costs. Citizens can expect faster access to groundbreaking therapies and medical tools.
Key points
A new agency, ARPA-H, is established as an independent operating division within the Department of Health and Human Services, focusing on high-risk, high-reward medical research.
The agency's goal is to develop revolutionary health technologies not currently addressed by other federal programs or private entities.
ARPA-H will support research into new methods for detecting, diagnosing, preventing, and treating serious diseases and medical conditions.
The agency's efforts are intended to contribute to reducing healthcare costs and ensuring the U.S. maintains global leadership in science and innovation.
Information regarding commercialization plans and project funding will be protected as confidential to foster innovation.
article Official text account_balance Process page
VOTING RESULTS
2022-06-22
80%
For 336
Against 85
Abstain 0
Full voting results open_in_new
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_5585
Sponsor: Rep. Eshoo, Anna G. [D-CA-18]
Process start date: 2021-10-15
Voting date: 2022-06-22
Meeting no: 2
Voting no: 288
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

ARPA–H Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_5585.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-10-15.

What are the main provisions?

Key points include:

  • A new agency, ARPA-H, is established as an independent operating division within the Department of Health and Human Services, focusing on high-risk, high-reward medical research.
  • The agency's goal is to develop revolutionary health technologies not currently addressed by other federal programs or private entities.
  • ARPA-H will support research into new methods for detecting, diagnosing, preventing, and treating serious diseases and medical conditions.
  • The agency's efforts are intended to contribute to reducing healthcare costs and ensuring the U.S. maintains global leadership in science and innovation.
  • Information regarding commercialization plans and project funding will be protected as confidential to foster innovation.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Where is the official voting record?

The official roll call vote is recorded at: voting record

Who is the primary sponsor?

The primary sponsor is Rep. Eshoo, Anna G. [D-CA-18].

What is the latest detailed status?

The latest detailed status is: On passage Passed by the Yeas and Nays: 336 - 85 (Roll no. 288).

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health Public Investments